Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pihlajalinna OyjFRA:38P +0.19%72 3-1 Month Momentum % is -4.93% as of Aug. 23, 2026. GuruFocus rates FRA:38P with a GF Score™ of 72/100 and a GF Value™ of €9.48 (Fairly Valued). The stock has 3 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Pihlajalinna Oyj ranks worse than 66.07% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-23), Pihlajalinna Oyj's 3-1 Month Momentum % is -4.93%.
The industry rank for Pihlajalinna Oyj's 3-1 Month Momentum % or its related term are showing as below:
FRA:38P's 3-1 Month Momentum % is ranked worse than 66.07% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: -1.36
vs FRA:38P: -4.93
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Pihlajalinna Oyj 3-1 Month Momentum % Related Terms
FRA:38P vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Pihlajalinna Oyj's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pihlajalinna Oyj 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pihlajalinna Oyj's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Pihlajalinna Oyj's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pihlajalinna Oyj (FRA:38P) has a 3-1 Month Momentum % of -4.93% as of Aug. 23, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Pihlajalinna Oyj and its competitors. According to the industry distribution chart, Pihlajalinna Oyj ranks #444 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 66.1%.
Is Pihlajalinna Oyj's 3-1 Month Momentum % too high?
Pihlajalinna Oyj's current 3-1 Month Momentum % is -4.93%. Based on the distribution chart, Pihlajalinna Oyj ranks #444 out of 672 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pihlajalinna Oyj has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pihlajalinna Oyj's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pihlajalinna Oyj ranks #444 out of 672 companies for 3-1 Month Momentum %. This places Pihlajalinna Oyj in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Pihlajalinna Oyj and its competitors. Pihlajalinna Oyj's current 3-1 Month Momentum % is -4.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pihlajalinna Oyj stock overvalued right now?
Based on GuruFocus' analysis, Pihlajalinna Oyj (FRA:38P) is currently considered Fairly Valued. The stock's GF Value™ is €9.48, compared to a current price of €10.36 — trading 9.3% above its estimated fair value. The current 3-1 Month Momentum % is -4.93%. Pihlajalinna Oyj's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Pihlajalinna Oyj (FRA:38P), the current 3-1 Month Momentum % is -4.93% as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pihlajalinna Oyj (FRA:38P) Overvalued in 2026?
Based on GuruFocus' analysis, Pihlajalinna Oyj stock appears to be overvalued.
The current stock price of €10.36 is trading 9.3% above its estimated GF Value™ of €9.48.
GuruFocus considers Pihlajalinna Oyj to be Fairly Valued.
Key valuation signals for FRA:38P:
3-1 Month Momentum %: -4.93%
GF Value™: €9.48 vs. price of €10.36 (9.3% above fair value)
No single metric tells the full story. See the FRA:38P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pihlajalinna Oyj is a private social and healthcare service providers in Finland. It provides comprehensive, high-quality services through private clinics, hospitals, remote channels, occupational healthcare, and tailored social and healthcare solutions for the public sector. It has two reportable segments: Private Healthcare Services and Public Services. The Private Healthcare Services operating segment consists of private clinic, diagnostics, hospital, occupational healthcare, remote and fitness center services. The Public Services operating segment consists of social and healthcare services produced for the public sector, which include outsourcing and housing services, mainly remotely produced responsible doctor services, as well as a wide range of staffing and recruitment services.
72GF Score
Get the complete analysis for FRA:38P
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:38P has been successfully added to your 
